New diabetes clinical trial: Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes
Published on: February 08, 2026 at 11:00PM Conditions : Stage 3 Type 1 Diabetes Interventions : Drug: AutoCD6-CAR Treg cells Sponsors : City of Hope Medical Center; National Cancer Institute (NCI) Not yet recruiting https://ift.tt/SWLso4q